Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma (MM)
收藏DataCite Commons2026-01-21 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012677/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the study is to determine whether the addition of Elotuzumab to Lenalidomide/low-dose Dexamethasone will increase the progression free survival (PFS).
提供机构：
Vivli
创建时间：
2026-01-21
